XPAND BIOTECHNOLOGY
Desconocido
InterLynk: Human Platelet Lysates based Scaffolds for Interfacial Multi tissue Repair
KUROS BIOSCIENCES BV
participó en un
H2020:
H2020-NMBP-TR-IND-2018-2020
InterLynk aims to develop multi-tissue 3D patient-specific scaffolds by providing a portfolio of highly compatible and biofunctional composi...
2020-12-02 - 2025-01-31 | Financiado
2020-12-02 - 2025-01-31 | Financiado
cmRNAbone: 3D Printed Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteopo...
KUROS BIOSCIENCES BV
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Due to life style changes and ageing of our industrialized nations, bone traumatic injuries and osteoporosis induced fragile fracture are an...
2019-11-24 - 2024-06-30 | Financiado
2019-11-24 - 2024-06-30 | Financiado
MUSIC: Multisystem Cell Therapy for Improvement of Urinary Continence
KUROS BIOSCIENCES BV
participó en un
H2020:
H2020-SC1-2016-2017
"Stress Urinary Incontinence (SUI) is a disease affecting over 200 million people worldwide. It represents a condition with a prevalence of...
2016-11-29 - 2022-03-31 | Financiado
2016-11-29 - 2022-03-31 | Financiado
CHARME: Growing bone fast and cost effective
KUROS BIOSCIENCES BV
tramitó un
H2020:
H2020-SMEInst-2014-2015
XPAND Biotechnology BV has developed a new generation of orthopaedic materials: the EpitaxOs bone regeneration material.
EpitaxOs (TRL 6)...
2015-07-10 - 2017-06-30 | Financiado
2015-07-10 - 2017-06-30 | Financiado
STELLAR: Stem cell based therapy for kidney repair
KUROS BIOSCIENCES BV
participó en un
FP7:
Chronic kidney disease (CKD) affects 8% of the European population and ultimately results in renal failure due to progressive fibrosis. CDK...
Financiado
Financiado
STEMEXPAND: Stem Cell Expansion Expansion and engraftment of haematopoietic and mesenchymal stem cells
KUROS BIOSCIENCES BV
participó en un
FP7:
Serious disorders of the blood system, particularly malignant blood disorders and genetic diseases can be effectively treated by blood and m...
Financiado
Financiado
RAPIDOS: Rapid Prototyping of Custom Made Bone Forming Tissue Engineering Constructs.
KUROS BIOSCIENCES BV
participó en un
FP7:
In cranio-maxillofacial surgery, large blow-out orbital floor fractures have still mitigated outcomes and improved scaffold solutions are ne...
Financiado
Financiado
REACH: bioREACtor for stem cell tHerapy
KUROS BIOSCIENCES BV
participó en un
FP7:
The REACH-project is a direct result of the FP7 StemExpand project, which aimed at the expansion and engraftment of hematopoietic and mesenc...
Financiado
Financiado
REBORNE: Regenerating Bone defects using New biomedical Engineering approaches
KUROS BIOSCIENCES BV
participó en un
FP7:
Bone is among the most frequently transplanted tissue with about 1 million procedures annually in Europe. The worldwide market of bone repla...
Financiado
Financiado
* No se disponen de datos de la empresa actual.